Rambam Health Care Campus ( Site 5501) — Haifa

Public research footprint of Rambam Health Care Campus ( Site 5501), compiled from the ClinicalTrials.gov public registry.

799

Registered studies

292

Active

168

Recruiting now

315

Completed

100

Stopped or withdrawn

Most-studied conditions

Ovarian Cancer · Diabetic Macular Edema (DME) · HR Low-Positive/HER2-Negative Breast Neoplasms · Triple Negative Breast Neoplasms

Recently updated registry entries

NCT05927571 — A Study Evaluating the Safety, Pharmacokinetics, and Activity of the Combination of… (Recruiting)
NCT07623161 — A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are… (Recruiting)
NCT07413939 — RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Rambam Health Care Campus ( Site 5501)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.